Polymer-coated nanoparticles to promote drug delivery to the brain — ScienceDaily

Treating diseases such as Alzheimer’s or Parkinson’s is a challenge because drugs have to be able to cross the blood-brain barrier. As a result, the doses administered must be high and only a small fraction reaches the brain, which can lead to significant systemic side effects. To solve this…

Click here to view the original article.